Donna Chang, CEO at Hope Biosciences in Sugar Land, Texas shares insights about the past, present and future of stem cell science and research.
Chang talks about growing non-embryonic-origin mesenchymal stem cells in dosages ample enough to serve as effective treatments and also the banking of an individual’s stem cells for use later in life.
Clinical research trials, conducted through Hope Bioscience’s foundation, include treatment protocols for Parkinson’s disease, Cerebral Palsy, spinal cord injury, Primary Lateral Sclerosis, chronic musculoskeletal pain, traumatic brain injury, Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus and more.
You are invited to subscribe to the six time Lowell Thomas Award-winning travel podcast, Journeys of Discovery with Tom Wilmer, featured on the NPR Podcast Directory, Apple Podcast, iHeartRadio,the NPR One App & Stitcher.com.
